Typical dose

Melatonin: 0.5-10 mg before bedtime. Ramelteon:...

Oral Oral safety: very low

About this supplement

Melatonin with receptor-specific analogs refers to formulations combining the endogenous hormone melatonin with synthetic analogs like ramelteon that selectively target melatonin receptors (primarily MT1 and MT2) in the suprachiasmatic nucleus. Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone produced by the pineal gland that regulates circadian rhythms and sleep-wake cycles. Receptor-specific analogs like ramelteon are designed to have higher affinity and selectivity for melatonin receptors, potentially offering improved pharmacokinetic profiles, longer half-lives, and reduced off-target effects compared to natural melatonin. These formulations aim to enhance sleep initiation and maintenance through targeted pharmacological action on the body's sleep-regulating pathways.

How much to take

Typical amount
Melatonin: 0.5-10 mg before bedtime. Ramelteon: 8 mg before bedtime. Combination formulations vary based on specific analog ratios.
Suggested range
Melatonin: 0.5-5 mg daily at bedtime; Ramelteon: 8 mg daily at bedtime; consult specific product labeling for combination formulations.

Potential benefits

Benefits linked to this supplement form:

Things to watch for

Possible side effects linked to this form:

Health goals

Needs and goals this form may help with:

Other forms of Melatonin

Compare absorption and active amounts with sibling forms:

Technical details â–¼

Chemical ID (CAS)

Melatonin: 73-31-4; Ramelteon: 196597-26-9

Formula

Melatonin: C13H16N2O2; Ramelteon: C16H21NO2

Physical properties

Melatonin: White to off-white crystalline powder, sparingly soluble in water, soluble in ethanol and DMSO. Ramelteon: White crystalline solid. Formulations often as tablets or capsules with various excipients for controlled release.

How it’s made

Melatonin is commercially produced via chemical synthesis from starting materials like 5-methoxyindole, avoiding animal sources. Ramelteon is synthesized through multi-step organic chemistry processes to create the specific receptor-targeting analog structure. Combination products are manufactured by blending melatonin with analog compounds in precise ratios, often using pharmaceutical-grade compression or encapsulation techniques.